Smoking can double risk of developing multiple sclerosis - especially in men

Science Editor,Steve Connor
Tuesday 28 October 2003 01:00
Comments

Smokers are at greater risk of developing multiple sclerosis, according to a study that has established the first clear link between smoking and the nerve disease.

Scientists found that smokers in their forties were almost twice as likely as non-smokers to develop MS in later life, with male smokers having 2.7 times the risk.

The study examined 87 MS patients in a sample of 22,312 people between the ages of 40 and 47 in the Norwegian county of Hordaland, in order to identify the environmental factors that increase the chances of developing the disease. Professor Trond Riise, of the University of Bergen, said: "This is the first time that smoking has been established as a risk factor ... Hopefully, these results will help us to learn more about what causes MS by looking at how smoking affects the onset of disease."

Multiple sclerosis is an auto-immune disease brought about when the body's immune defences attack the fatty sheath of material that insulates and protects the nerve cells of the brain and spinal cord. Patients can suffer stiffness, spasticity, pain and general fatigue. The causes of the disease are thought to be a combination of genetic and environmental factors, such as viral infections that damage the central nervous system.

Professor Riise said the link with cigarettes might be because smokers are more prone to viral infections of the throat. Smoking is known to weaken the important tissue barrier between the blood and the brain, perhaps increasing the risk of viruses affecting the central nervous system. "There are several plausible mechanisms that could explain why smokers are at significantly higher risk than non-smokers. Smoking is known, for instance, to interfere generally with the immune system. Or if could be the direct toxic effects of nicotine," he said.

In addition to heart disease and lung cancer, smoking has already been linked with other diseases that are caused by a defective immune system, such as rheumatoid arthritis.

Mike O'Donovan, chief executive of the MS Society, said the findings needed to be verified with further research. "We must remember that more than one factor is almost certainly involved in whether MS occurs," he said.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in